Roger James Email & Phone Number

Cambridge Uk

Computiv was founded in 2006 but much of the work has been fitted around full-time roles in other organisations. It remains an active consulting and pragmatic research practice. Significant consultancy assignments include new IT Strategies for LifeScience Clients and IT effectiveness reviews in the public sector. The biggest single implementation was for a Japanese Pharmaceutical Firm at the core of a US-EU-Japan team commissioning the Trial Master File used to launch a next gen cardiovascular blockbuster reporting on a clinical trail of over 25000 patients.An exciting number of services have been developed across a number of key fields in partnership with sector leading groups. Key areas of Computiv practice are:->> Shared services and back office performance - with HE Associates>> Systems thinking in the public sector - with Watt Works>> Supporting distressed biotech companies - with Black Crow Ventures>> Strategic resource planning for downsizing - with Hays IT>> Improving government IT- with the Institute for Government>> Digital strategies for public opinion – for a leading Market Research Organisation>> Strategic re-skilling of IT – for a UK Pharmaceutical company>> Developing a Project management Culture – for a UK Pharmaceutical companyInvited contributions include Records Management in the Cloud, a Technologists controversial view of Information Science (a regular publication), Cost & Value in funding Public Infrastructures, Cost and Performance of Back-Office Services and a Neuroscience approach to Risk.

An honorary position and one which provides a great deal of personal interest and facilities to be part of a research community. It forms the perfect counterpoint to 'industry' allowing me to explore, in some depth, some of the challenges from industry and expose research thinking to the real world of industry.

Cambridge, Uk

My focus was to deliver the systems for the "big information" component of big data research into Rare Diseases. Our focus is to bring forward the research possibilities of improved diagnosis and new treatments in the treatment of Rare Disease. The big data science reveals the underlying causal mechanisms from developments in the *omics [specifically the UK's 100000 genome initiative and the advances in array Metabolomics or Proteomics].The challenge is to enable and encourage the collection of detailed clinical observations [the phenotypes] and provide the extended linked data sets ready for clinical breakthrough and as a team we cracked many of the data integration issues at the heart of the UK's programme across many of the 6000 rare diseases for our own research and for the 100000 genome project. Our efforts are at the practical frontier of clinical data management linked with big data!I will miss this important and noble endeavour but especially the truly nice people dedicated to the study participants who worked above any petty personal or company politics. Human Readable: Improving the usability of clinical electronic data capture to increase the depth of useful data capture and building a secure managed infrastructure for the different big data data sets. Computer Readable: OpenClinica, Ontologies, Linked Data, Data Security, Enterprise Service Bus, HPO, Snomed, ICD, Big Data

I started with the OU teaching Knowledge Management (1999-2005). In 2006 I launched a new MBA programme - in Strategic Life Sciences (BS811) aimed at Post-Graduate medical education. This course inverts the normal MBA structure and delivers a content rich MBA, with in-depth study of the Life Sciences rather than the more conventional generalist MBA.In 2011-2013 I was primary author for a new taught masters postgraduate course S811 (Strategic management in life sciences and healthcare). I developed the material on the state of the pharmaceutical business, innovation, investments and a simulation game for Biotech mergers.I will miss learning from the students and supporting the andragogy of real world practitioners.

The University of Westminster was seeking to improve their ranking in the league tables by a focus on research, by increasing the entry standards and by expanding their international franchise. The new VC introduced a programme of service improvement and consolidation of corporate services. Upon joining I produced a strategic review which restructured IT and gave responsibility for a combined £9m 120 person team for Systems, Business Support, Projects, HelpDesk, AV & Infrastructure. We then delivered the restructuring, managed in a heavily unionised environment without any recruitment, to produce an integrated front-line support service combining Library/IT and professional leadership for the core technology functions.Technical changes were equally dramatic we were the first UK institution to move fully onto onto Google Apps with a highly visible "we asked, you said, we did" campaign this saved £1m and was voted the #1 improvement to student life. We won a research project, TWOLER, which won the magnum award in the JISC Institutional Innovation Programme. This looked at how student contributions could add to our institutional systems "directed serendipity in Web 2.0" - terrific fun and a fantastic success. I will remember my time there for the fantastic people and their openness to new ideas.

An amazing organisation - with an emporium of talents, a stunning richness of material and the professionalism of the conservation work. My role was to lead the team developing their digital library infrastructure [a system of near infinite capacity to hold digital artefacts without corruption for hundreds of years]. The wealth of eclectic knowledge in the artefacts but more so in the people at the BL is my outstanding memory.

A break from traveling with Glaxo this role gave me the facility to live and work in Cambridge in a privately owned Pharmaceutical company. Big enough to be profitable and small enough to value their people, it was full of good people and working across R&D, Manufacturing and Sales. Whilst at Napp I was able to deliver ..>> Turnaround management of IT from regulatory condemnation to praise by the regulators for quality and recognised for their low cost of ownership (our Oracle ERP systems was bench-marked at a TCO 30% that of SAP).>> Improved customer satisfaction to over 95%.>> A Knowledge Worker environment for European R&D with Sharepoint, to accelerate new product development. >> Introduced Agile Methods in a regulated environment to improve development productivity by 200%.>> Innovation and company planning. Patent holder in medical informatics. It was a great place to develop the careers of my team which was clearly well appreciated - "pearls of wisdom, deep thoughts and experiences will be being used and shared through everyone that ever worked with him. You always remember the good bosses and the good teachers, Roger was both!"

(Actually Glaxo then GlaxoWellcome which is now GSK)The world's best job working on the future with some of the brightest people I have ever met. But challenged by the corporate miasma surrounding company merger.Really a fantastic opportunity to be funded to learn and experiment in a leading technology company. Tremendous opportunity to take assignments in everything from IT futures, the impact of genetics, developing new markets, the impact of electronic on healthcare to corporate strategy.Thank you Glaxo I really enjoyed my time with you!

London, United Kingdom

Business Area Manager with technical and profit responsibility for CAP Scientific's civil sector work. A great job full of experience and challenge and my introduction to the best practices in computing.The best part of the job was to work on really hard real world problems such as the Best Practical Environmental Options for Nuclear Waste Disposal and designing low energy buildings.A terrific place to learn and get to know lifelong colleagues.

Phd, Theoretical Physics / Chemistry

Activities and Societies: On the Defect Structure of Rutile and Corrundum Oxides

Ma, Chemistry

Activities and Societies: St Catherine's College

Master Of Arts - Ma, Chemistry